Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception?

Addiction

Volumn 107, Issue 6, 2012, Pages 1036-1041

  Lucke, Jayne C ^a   Hall, Wayne D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Coercion; Contraception; Drug treatment; Informed consent; Reproductive health; Reproductive rights; Substance abuse

Indexed keywords

ADDICTION; ARTICLE; BIOETHICS; CONTRACEPTION; ECONOMICS; ETHICS; FEMALE; HEALTH SERVICE; HUMAN; INFORMED CONSENT; PRACTICE GUIDELINE; PREGNANCY; REPRODUCTIVE RIGHTS; REWARD; UNPLANNED PREGNANCY;

BIOETHICAL ISSUES; CONTRACEPTION; FEMALE; HUMANS; INFORMED CONSENT; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY, UNPLANNED; REPRODUCTIVE HEALTH SERVICES; REPRODUCTIVE RIGHTS; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 84860573275     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03699.x     Document Type: Article

References (58)

1. Project Prevention. Project Prevention 2011. Available at: ; archived at: (accessed 28 April 2011).
2. American Public Health Association. Opposition to coercion in family planning decision making. Am J Public Health 2002; 92: 474-75.
3. Boyer A. When pregnant women use drugs: what are the real problems and what can society do to solve them? J Law Soc 2003; 5: 137-54.
4. Chelian R. Remarks on the 'CRACK' program: coercing women's reproductive choices. J Law Soc 2003; 5: 187-98.
5. Cummings S. Is CRACK the cure? J Law Soc 2003; 5: 1-10.
6. Fenton Z. Project prevention: cash for birth control, a solution or a violation of rights? J Law Soc 2003; 5: 199-228.
7. Murphy J., Pugsley R. Successful pregnancy prevention program for addicts remains under seige. J Law Soc 2003; 5: 155-86.
8. Paltrow L. Why caring communities must oppose C.R.A.C.K./project prevention: how C.R.A.C.K. promotes dangerous prooaganda and undermines the health and well being of children and families. J Law Soc 2003; 5: 11-117.
9. Eckenwiler L. Why not retribution? The particularized imagination and justice for pregnant addicts. J Law Med Ethics 2004; 32: 89-99.
10. Jos P. H., Perlmutter M., Marshall M. F. Substance abuse during pregnancy: clinical and public health approaches. J Law Med Ethics 2003; 31: 340-50.
11. Morgan M. The payment of drug addicts to increase their sterilisation rate is morally unjustified and not simply 'a fine balance'. J Obstet Gynaecol 2004; 24: 119-23.
12. Gregory J. (M)Others in altered states: prenatal drug-use, risk, choice, and responsible self-governance. Soc Legal Stud 2010; 19: 49-66.
13. Limb M. Charity pays drug addicts to use long term contraception. BMJ 2011; 342: d1575.
14. Medical Net. Project Prevention Feels It Is Crucial to Educate HIV/AIDS Positive Women on Long Term Birth Control, 2010. Available at: ; archived at: (accessed 28 April 2011).
15. Carey A. Charity 'preys on weak, addicted'. The Age. 20 October 2010. Available at: ; archived at (accessed 10 April 2011).
16. Beauchamp T. L., Childress J. F. Principles of Biomedical Ethics. Oxford: Oxford University Press; 2001.
17. Heil S. H., Jones H. E., Arria A., Kaltenbach K., Coyle M., Fischer G. etal. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat 2011; 40: 199-202.
18. Sharpe T. T., Velasquez M. M. Risk of alcohol-exposed pregnancies among low-income, illicit drug-using women. J Womens Health (Larchmt) 2008; 17: 1339-44.
19. Henshaw S. K. Unintended pregnancy in the United States. Fam Plann Perspect 1998; 30: 24-9.
20. Trussell J., Wynn L. L. Reducing unintended pregnancy in the United States. Contraception 2008; 77: 1-5.
21. Rosenbaum M., Murphy S. Women and addiction: process, treatment, and outcome. In: Lambert E. Y., editor. The Collection and Interpretation of Data from Hidden Populations, Rockville: National Institute on Drug Abuse; 1990, p. 120-7.
22. Kuczkowski K. M. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007; 19: 578-85.
23. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, MD: US Department of Health and Human Services; 2010. Available at: ; archived at (accessed 15 April 2011).
24. Terplan M., Wright T. The effects of cocaine and amphetamine use during pregnancy on the newborn: myth versus reality. J Addict Dis 2011; 30: 1-5.
25. Madgula R. M., Groshkova T., Mayet S. Illicit drug use in pregnancy: effects and management. Exp Rev Obstet Gynecol 2011; 6: 179-92.
26. Shankaran S., Lester B. M., Das A., Bauer C. R., Bada H. S., Lagasse L. etal. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 2007; 12: 143-50.
27. Huizink A. C., Mulder E. J. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 2006; 30: 24-41.
28. Lester B. M., Tronick E. Z., LaGasse L., Seifer R., Bauer C. R., Shankaran S. etal. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110: 1182-92.
29. Flavin J., Paltrow L. M. Punishing pregnant drug-using women: defying law, medicine, and common sense. J Addict Dis 2010; 29: 231-44.
30. Boyd S. C. Mothers and Illicit Drugs: Transcending the Myths. Toronto: University of Toronto Press; 1999.
31. Kearney M. H., Murphy S., Rosenbaum M. Mothering on crack cocaine: a grounded theory analysis. Soc Sci Med 1994; 38: 351-61.
32. Klee H., Jackson M., Lewis S. Drug Misuse and Motherhood. London: Routledge; 2002.
33. Conners N. A., Bradley R. H., Mansell L. W., Liu J. Y., Roberts T. J., Burgdorf K. etal. Children of mothers with serious substance abuse problems: an accumulation of risks. Am J Drug Alcohol Abuse 2004; 30: 85-100.
34. Oringanje C., Meremikwu M. M., Eko H., Esu E., Meremikwu A., Ehiri J. E. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2009; 1: CD005215.
35. Elfenbein D. S., Felice M. E. Adolescent pregnancy. Pediatr Clin North Am 2003; 50: 781-800.
36. Berghella V., Buchanan E., Pereira L., Baxter J. K. Preconception care. Obstet Gynecol Surv 2010; 65: 119-31.
37. Lim S. Y. Protecting the unborn as modern day eugenics. Health Matrix Clevel 2008; 18: 127-36.
38. Weed D. L. Precaution, prevention, and public health ethics. J Med Philos 2004; 29: 313-32.
39. Jaffe H. W., Hope T. Treating for the common good: a proposed ethical framework. Public Health Ethics 2010; 3: 193-8.
40. Meade C. S. Sexual risk behavior among persons dually diagnosed with severe mental illness and substance use disorder. J Subst Abuse Treat 2006; 30: 147-57.
41. van den Hoek A. STD control in drug users and street youth. Genitourin Med 1997; 73: 240-4.
42. Overton E. T., Shacham E., Singhatiraj E., Nurutdinova D. Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception. Contraception 2008; 78: 125-30.
43. Morrison C. S., Turner A. N., Jones L. B. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009; 23: 263-84.
44. Fry C. L., Hall W., Ritter A., Jenkinson R. The ethics of paying drug users who participate in research: a review and practical recommendations. J Empir Res Hum Res Ethics 2006; 1: 21-36.
45. Marteau T. M., Ashcroft R. E., Oliver A. Using financial incentives to achieve healthy behaviour. BMJ 2009; 338: 983-5.
46. Australian Associated Press (AAP). Young Australians to receive $10 to undergo STD test. Herald Sun. 1 February 2011. Available at: ; archived at (accessed 10 April 2011).
47. Lussier J. P., Heil S. H., Mongeon J. A., Badger G. J., Higgins S. T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006; 101: 192-203.
48. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2007; 101: 1546-60.
49. Rawson R. A., McCann M. J., Flammino F., Shoptaw S., Miotto K., Reiber C. etal. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 2006; 101: 267-74.
50. Warren C., Abuya T., Obare F., Sunday J., Njue R., Askew I. etal. Evaluation of the impact of the voucher and accreditation approach on improving reproductive health behaviors and status in Kenya. BMC Public Health 2011; 11: 177-85.
51. National Collaborating Centre for Women's and Children's Health. Long-Acting Reversible Contraception: The Effective and Appropriate Use of Long-Acting Reversible Contraception. London: RCOG Press; 2005. Available at: ; archived at (accessed 3 October 2008).
52. Stoddard A., McNicholas C., Peipert J. F. Efficacy and safety of long-acting reversible contraception. Drugs 2011; 71: 969-80.
53. Phillips T. Exploitation in payments to research subjects. Bioethics 2011; 25: 209-19.
54. Festinger D. S., Marlowe D. B., Croft J. R., Dugosh K. L., Mastro N. K., Lee P. A. etal. Do research payments precipitate drug use or coerce participation? Drug Alcohol Depend 2005; 78: 275-81.
55. Vandrey R., Bigelow G. E., Stitzer M. L. Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives. Exp Clin Psychopharmacol 2007; 15: 338-43.
56. Lambert B., Scheiner M., Campbell D. Ethical issues and addiction. J Addict Dis 2010; 29: 164-74.
57. Carter A., Hall W. The issue of consent in research that administers drugs of addiction to addicted persons. Account Res 2008; 15: 209-25.
58. Lucke J. C., Watson M., Herbert D. Changing patterns of contraceptive use in Australian women. Contraception 2009; 80: 533-9.